메뉴 건너뛰기




Volumn 22, Issue 1, 2015, Pages

Preparation, characterization and immunological evaluation: Canine parvovirus synthetic peptide loaded plga nanoparticles

Author keywords

Antigen; Antigen delivery; Canine Parvovirus; Nanoparticle; Peptide; PLGA; Vaccine

Indexed keywords

LACTIC ACID; NANOPARTICLE; PEPTIDE; POLYGLYCOLIC ACID; POLYLACTIC ACID-POLYGLYCOLIC ACID COPOLYMER;

EID: 84944392078     PISSN: 10217770     EISSN: 14230127     Source Type: Journal    
DOI: 10.1186/s12929-015-0195-2     Document Type: Article
Times cited : (60)

References (55)
  • 1
    • 84896502095 scopus 로고    scopus 로고
    • Synthesıs and characterızatıon of canıne parvovırus (CPV) VP2 W-7L-20 synthetıc peptıde for synthetıc vaccıne
    • Derman S, Kizilbey K, Mansuroglu B, Mustafaeva Z. Synthesıs and characterızatıon of canıne parvovırus (CPV) VP2 W-7L-20 synthetıc peptıde for synthetıc vaccıne. Fresenıus Envıronmental Bull. 2014;23(2 A):558-66.
    • (2014) Fresenıus Envıronmental Bull , vol.23 , Issue.2 , pp. 558-566
    • Derman, S.1    Kizilbey, K.2    Mansuroglu, B.3    Mustafaeva, Z.4
  • 2
    • 13444274355 scopus 로고    scopus 로고
    • Canine parvoviral enteritis: A review of diagnosis, management, and prevention
    • Prittie J. Canine parvoviral enteritis: a review of diagnosis, management, and prevention. J Vet Emerg Crit Care. 2004;14(3):167-76.
    • (2004) J Vet Emerg Crit Care , vol.14 , Issue.3 , pp. 167-176
    • Prittie, J.1
  • 4
    • 0029847222 scopus 로고    scopus 로고
    • Detection of canine parvovirus antigens with antibodies to synthetic peptides
    • Vihinen-Ranta M, Lindfors E, Heiska L, Veijalainen P, Vuento M. Detection of canine parvovirus antigens with antibodies to synthetic peptides. Arch Virol. 1996;141(9):1741-8.
    • (1996) Arch Virol , vol.141 , Issue.9 , pp. 1741-1748
    • Vihinen-Ranta, M.1    Lindfors, E.2    Heiska, L.3    Veijalainen, P.4    Vuento, M.5
  • 5
    • 13444271030 scopus 로고
    • Effectiveness of fluids and antibiotics as supportive therapy of canine parvovirus-2 enteritis in puppies
    • Kariuki NM, Nyaga P, Buoro I, Gathumbi P. Effectiveness of fluids and antibiotics as supportive therapy of canine parvovirus-2 enteritis in puppies. Bull Anim Health Prod Afr. 1990;38:379-89.
    • (1990) Bull Anim Health Prod Afr , vol.38 , pp. 379-389
    • Kariuki, N.M.1    Nyaga, P.2    Buoro, I.3    Gathumbi, P.4
  • 6
    • 0028856089 scopus 로고
    • Peptide vaccine against canine parvovirus: Identification of two neutralization subsites in the N terminus of VP2 and optimization of the amino acid sequence
    • Casal JI, Langeveld J, Cortes E, Schaaper W, van Dijk E, Vela C, et al. Peptide vaccine against canine parvovirus: identification of two neutralization subsites in the N terminus of VP2 and optimization of the amino acid sequence. J Virol. 1995;69(11):7274-7.
    • (1995) J Virol , vol.69 , Issue.11 , pp. 7274-7277
    • Casal, J.I.1    Langeveld, J.2    Cortes, E.3    Schaaper, W.4    van Dijk, E.5    Vela, C.6
  • 7
    • 0028271128 scopus 로고
    • First peptide vaccine providing protection against viral infection in the target animal: Studies of canine parvovirus in dogs
    • Langeveld J, Casal JI, Osterhaus A, Cortes E, De Swart R, Vela C, et al. First peptide vaccine providing protection against viral infection in the target animal: studies of canine parvovirus in dogs. J Virol. 1994;68(7):4506-13.
    • (1994) J Virol , vol.68 , Issue.7 , pp. 4506-4513
    • Langeveld, J.1    Casal, J.I.2    Osterhaus, A.3    Cortes, E.4    de Swart, R.5    Vela, C.6
  • 10
    • 14544272789 scopus 로고    scopus 로고
    • Microencapsulation peptide and protein drugs delivery system
    • Dai C, Wang B, Zhao H. Microencapsulation peptide and protein drugs delivery system. Colloids Surf B Biointerfaces. 2005;41(2):117-20.
    • (2005) Colloids Surf B Biointerfaces , vol.41 , Issue.2 , pp. 117-120
    • Dai, C.1    Wang, B.2    Zhao, H.3
  • 11
    • 84876944573 scopus 로고    scopus 로고
    • A single-dose PLGA encapsulated protective antigen domain 4 nanoformulation protects mice against Bacillus anthracis spore challenge
    • Manish M, Rahi A, Kaur M, Bhatnagar R, Singh S. A single-dose PLGA encapsulated protective antigen domain 4 nanoformulation protects mice against Bacillus anthracis spore challenge. PLoS One. 2013;8(4), e61885.
    • (2013) PLoS One , vol.8 , Issue.4
    • Manish, M.1    Rahi, A.2    Kaur, M.3    Bhatnagar, R.4    Singh, S.5
  • 15
    • 77949742766 scopus 로고    scopus 로고
    • Microencapsulation of vaccine antigens and adjuvants for mucosal targeting
    • Rajapaksa TE, Lo DD. Microencapsulation of vaccine antigens and adjuvants for mucosal targeting. Curr Immunol Rev. 2010;6(1):29-37.
    • (2010) Curr Immunol Rev , vol.6 , Issue.1 , pp. 29-37
    • Rajapaksa, T.E.1    Lo, D.D.2
  • 16
    • 33751253462 scopus 로고    scopus 로고
    • Nanoparticles as potential oral delivery systems of proteins and vaccines: A mechanistic approach
    • des Rieux A, Fievez V, Garinot M, Schneider Y-J, Préat V. Nanoparticles as potential oral delivery systems of proteins and vaccines: a mechanistic approach. J Control Release. 2006;116(1):1-27.
    • (2006) J Control Release , vol.116 , Issue.1 , pp. 1-27
    • des Rieux, A.1    Fievez, V.2    Garinot, M.3    Schneider, Y.-J.4    Préat, V.5
  • 17
    • 11844263890 scopus 로고    scopus 로고
    • Enhancement of T helper type 1 immune responses against hepatitis B virus core antigen by PLGA nanoparticle vaccine delivery
    • Chong CS, Cao M, Wong WW, Fischer KP, Addison WR, Kwon GS, et al. Enhancement of T helper type 1 immune responses against hepatitis B virus core antigen by PLGA nanoparticle vaccine delivery. J Control Release. 2005;102(1):85-99.
    • (2005) J Control Release , vol.102 , Issue.1 , pp. 85-99
    • Chong, C.S.1    Cao, M.2    Wong, W.W.3    Fischer, K.P.4    Addison, W.R.5    Kwon, G.S.6
  • 18
    • 33646139149 scopus 로고    scopus 로고
    • Strong systemic and mucosal immune responses to surface-modified PLGA microspheres containing recombinant hepatitis B antigen administered intranasally
    • Jaganathan K, Vyas SP. Strong systemic and mucosal immune responses to surface-modified PLGA microspheres containing recombinant hepatitis B antigen administered intranasally. Vaccine. 2006;24(19):4201-11.
    • (2006) Vaccine , vol.24 , Issue.19 , pp. 4201-4211
    • Jaganathan, K.1    Vyas, S.P.2
  • 19
    • 84864410996 scopus 로고    scopus 로고
    • Biodegradable PLGA85/15 nanoparticles as a delivery vehicle for Chlamydia trachomatis recombinant MOMP-187 peptide
    • Taha MA, Singh SR, Dennis VA. Biodegradable PLGA85/15 nanoparticles as a delivery vehicle for Chlamydia trachomatis recombinant MOMP-187 peptide. Nanotechnology. 2012;23(32):325101.
    • (2012) Nanotechnology , vol.23 , Issue.32 , pp. 325101
    • Taha, M.A.1    Singh, S.R.2    Dennis, V.A.3
  • 20
    • 84888343277 scopus 로고    scopus 로고
    • Effects of Caryota mitis profilin-loaded PLGA nanoparticles in a murine model of allergic asthma
    • Xiao X, Zeng X, Zhang X, Ma L, Liu X, Yu H, et al. Effects of Caryota mitis profilin-loaded PLGA nanoparticles in a murine model of allergic asthma. Int J Nanomedicine. 2013;8:4553.
    • (2013) Int J Nanomedicine , vol.8 , pp. 4553
    • Xiao, X.1    Zeng, X.2    Zhang, X.3    Ma, L.4    Liu, X.5    Yu, H.6
  • 21
    • 84866747868 scopus 로고    scopus 로고
    • PLGA nanoparticle-mediated delivery of tumor antigenic peptides elicits effective immune responses
    • Ma W, Chen M, Kaushal S, McElroy M, Zhang Y, Ozkan C, et al. PLGA nanoparticle-mediated delivery of tumor antigenic peptides elicits effective immune responses. Int J Nanomedicine. 2012;7:1475.
    • (2012) Int J Nanomedicine , vol.7 , pp. 1475
    • Ma, W.1    Chen, M.2    Kaushal, S.3    McElroy, M.4    Zhang, Y.5    Ozkan, C.6
  • 22
    • 34548863653 scopus 로고    scopus 로고
    • Lectin-conjugated PLGA nanoparticles loaded with thymopentin:< i > Ex vivo bioadhesion and < i > in vivo biodistribution
    • Yin Y, Chen D, Qiao M, Wei X, Hu H. Lectin-conjugated PLGA nanoparticles loaded with thymopentin:< i > Ex vivo bioadhesion and < i > in vivo biodistribution. J Control Release. 2007;123(1):27-38.
    • (2007) J Control Release , vol.123 , Issue.1 , pp. 27-38
    • Yin, Y.1    Chen, D.2    Qiao, M.3    Wei, X.4    Hu, H.5
  • 23
    • 84892817368 scopus 로고    scopus 로고
    • PH-and temperature-responsive amphiphilic diblock copolymers of 4-vinylpyridine and oligoethyleneglycol methacrylate synthesized by RAFT polymerization
    • Topuzogullari M, Bulmus V, Dalgakiran E, Dincer S. pH-and temperature-responsive amphiphilic diblock copolymers of 4-vinylpyridine and oligoethyleneglycol methacrylate synthesized by RAFT polymerization. Polymer. 2014;55(2):525-34.
    • (2014) Polymer , vol.55 , Issue.2 , pp. 525-534
    • Topuzogullari, M.1    Bulmus, V.2    Dalgakiran, E.3    Dincer, S.4
  • 24
    • 84858843984 scopus 로고    scopus 로고
    • Practical preparation procedures for docetaxel-loaded nanoparticles using polylactic acid-co-glycolic acid
    • Keum C-G, Noh Y-W, Baek J-S, Lim J-H, Hwang C-J, Na Y-G, et al. Practical preparation procedures for docetaxel-loaded nanoparticles using polylactic acid-co-glycolic acid. Int J Nanomedicine. 2011;6:2225.
    • (2011) Int J Nanomedicine , vol.6 , pp. 2225
    • Keum, C.-G.1    Noh, Y.-W.2    Baek, J.-S.3    Lim, J.-H.4    Hwang, C.-J.5    Na, Y.-G.6
  • 25
    • 84905254847 scopus 로고    scopus 로고
    • Poly (lactic acid)-poly (ethylene glycol) nanoparticles provide sustained delivery of a < i > Chlamydia trachomatis recombinant MOMP peptide and potentiate systemic adaptive immune responses in mice
    • 201410
    • Dixit S, Singh SR, Yilma AN, Agee II RD, Taha M, Dennis VA. Poly (lactic acid)-poly (ethylene glycol) nanoparticles provide sustained delivery of a < i > Chlamydia trachomatis recombinant MOMP peptide and potentiate systemic adaptive immune responses in mice. Nanomedicine: NBM. 201410(6):1311-1321.
    • Nanomedicine: NBM , Issue.6 , pp. 1311-1321
    • Dixit, S.1    Singh, S.R.2    Yilma, A.N.3    Agee, R.D.4    Taha, M.5    Dennis, V.A.6
  • 26
    • 0003629391 scopus 로고    scopus 로고
    • Inc S. Chicago, Illinois, USA: SPSS Inc
    • Inc S. SPSS for Windows version 15.0. Chicago, Illinois, USA: SPSS Inc; 2006.
    • (2006) SPSS for Windows Version 15.0
  • 27
    • 84858115907 scopus 로고    scopus 로고
    • Biodegradable nanoparticles as vaccine adjuvants and delivery systems: Regulation of immune responses by nanoparticle-based vaccine
    • Springer; Berlin, Germany
    • Akagi T, Baba M, Akashi M. Biodegradable nanoparticles as vaccine adjuvants and delivery systems: regulation of immune responses by nanoparticle-based vaccine. Polymers in Nanomedicine. Springer; Berlin, Germany. 2012, pp. 31-64.
    • (2012) Polymers in Nanomedicine , pp. 31-64
    • Akagi, T.1    Baba, M.2    Akashi, M.3
  • 28
    • 84870238185 scopus 로고    scopus 로고
    • Biodegradation and biocompatibility of PLA and PLGA microspheres
    • Anderson JM, Shive MS. Biodegradation and biocompatibility of PLA and PLGA microspheres. Adv Drug Deliv Rev. 2012;64:72-82.
    • (2012) Adv Drug Deliv Rev , vol.64 , pp. 72-82
    • Anderson, J.M.1    Shive, M.S.2
  • 29
    • 79953163482 scopus 로고    scopus 로고
    • Relationship between the size of nanoparticles and their adjuvant activity: Data from a study with an improved experimental design
    • Li X, Sloat BR, Yanasarn N, Cui Z. Relationship between the size of nanoparticles and their adjuvant activity: data from a study with an improved experimental design. Eur J Pharm Biopharm. 2011;78(1):107-16.
    • (2011) Eur J Pharm Biopharm , vol.78 , Issue.1 , pp. 107-116
    • Li, X.1    Sloat, B.R.2    Yanasarn, N.3    Cui, Z.4
  • 30
    • 16644395235 scopus 로고    scopus 로고
    • Delivery of tumor antigens to dendritic cells using biodegradable microspheres
    • Springer; Zurich, Switzerland
    • Waeckerle-Men Y., Gander B, Groettrup M. Delivery of tumor antigens to dendritic cells using biodegradable microspheres. Adoptive Immunotherapy: Methods and Protocols. Springer; Zurich, Switzerland 2005. pp. 35-46
    • (2005) Adoptive Immunotherapy: Methods and Protocols , pp. 35-46
    • Waeckerle-Men, Y.1    Gander, B.2    Groettrup, M.3
  • 31
    • 75449093784 scopus 로고    scopus 로고
    • The effect of poloxamer 188 on nanoparticle morphology, size, cancer cell uptake, and cytotoxicity
    • Yan F, Zhang C, Zheng Y, Mei L, Tang L, Song C, et al. The effect of poloxamer 188 on nanoparticle morphology, size, cancer cell uptake, and cytotoxicity. Nanomedicine: NBM. 2010;6(1):170-8.
    • (2010) Nanomedicine: NBM , vol.6 , Issue.1 , pp. 170-178
    • Yan, F.1    Zhang, C.2    Zheng, Y.3    Mei, L.4    Tang, L.5    Song, C.6
  • 33
    • 33645776262 scopus 로고    scopus 로고
    • Pharmaceutical and immunological evaluation of a single-dose hepatitis B vaccine using PLGA microspheres
    • Feng L, Qi XR, Zhou XJ, Maitani Y, Cong WS, Jiang Y, et al. Pharmaceutical and immunological evaluation of a single-dose hepatitis B vaccine using PLGA microspheres. J Control Release. 2006;112(1):35-42.
    • (2006) J Control Release , vol.112 , Issue.1 , pp. 35-42
    • Feng, L.1    Qi, X.R.2    Zhou, X.J.3    Maitani, Y.4    Cong, W.S.5    Jiang, Y.6
  • 34
    • 0029558085 scopus 로고
    • Immunization with a soluble recombinant HIV protein entrapped in biodegradable microparticles induces HIV-specific cytotoxic T lymphocytes and cells
    • Moore A, McGuirk P, Adams S, Jones WC, Paul MGJ, O'Hagan DT, et al. Immunization with a soluble recombinant HIV protein entrapped in biodegradable microparticles induces HIV-specific cytotoxic T lymphocytes and Th1 cells. Vaccine. 1995;13(18):1741-9.
    • (1995) Vaccine , vol.13 , Issue.18 , pp. 1741-1749
    • Moore, A.1    McGuirk, P.2    Adams, S.3    Jones, W.C.4    Paul, M.G.J.5    O'Hagan, D.T.6
  • 35
    • 0028876363 scopus 로고
    • Synthetic delivery system for tuberculosis vaccines: Immunological evaluation of the < i > M. Tuberculosis 38 kDa protein entrapped in biodegradable PLG microparticles
    • Vordermeier H, Coombes A, Jenkins P, McGee J, O'Hagan D, Davis S, et al. Synthetic delivery system for tuberculosis vaccines: immunological evaluation of the < i > M. tuberculosis 38 kDa protein entrapped in biodegradable PLG microparticles. Vaccine. 1995;13(16):1576-82.
    • (1995) Vaccine , vol.13 , Issue.16 , pp. 1576-1582
    • Vordermeier, H.1    Coombes, A.2    Jenkins, P.3    McGee, J.4    O'Hagan, D.5    Davis, S.6
  • 36
    • 83655165245 scopus 로고    scopus 로고
    • Poly lactic-co-glycolic acid (PLGA) as biodegradable controlled drug delivery carrier
    • Makadia HK, Siegel SJ. Poly lactic-co-glycolic acid (PLGA) as biodegradable controlled drug delivery carrier. Polymers. 2011;3(3):1377-97.
    • (2011) Polymers , vol.3 , Issue.3 , pp. 1377-1397
    • Makadia, H.K.1    Siegel, S.J.2
  • 37
    • 79961079794 scopus 로고    scopus 로고
    • Intracellular targeting of PLGA nanoparticles encapsulating antigenic peptide to the endoplasmic reticulum of dendritic cells and its effect on antigen cross-presentation in vitro
    • Sneh-Edri H, Likhtenshtein D, Stepensky D. Intracellular targeting of PLGA nanoparticles encapsulating antigenic peptide to the endoplasmic reticulum of dendritic cells and its effect on antigen cross-presentation in vitro. Mol Pharm. 2011;8(4):1266-75.
    • (2011) Mol Pharm , vol.8 , Issue.4 , pp. 1266-1275
    • Sneh-Edri, H.1    Likhtenshtein, D.2    Stepensky, D.3
  • 38
    • 84878430358 scopus 로고    scopus 로고
    • Chlamydia trachomatis recombinant MOMP encapsulated in PLGA nanoparticles triggers primarily T helper 1 cellular and antibody immune responses in mice: A desirable candidate nanovaccine
    • Fairley SJ, Singh SR, Yilma AN, Waffo AB, Subbarayan P, Dixit S, et al. Chlamydia trachomatis recombinant MOMP encapsulated in PLGA nanoparticles triggers primarily T helper 1 cellular and antibody immune responses in mice: a desirable candidate nanovaccine. Int J Nanomedicine. 2013;8:2085.
    • (2013) Int J Nanomedicine , vol.8 , pp. 2085
    • Fairley, S.J.1    Singh, S.R.2    Yilma, A.N.3    Waffo, A.B.4    Subbarayan, P.5    Dixit, S.6
  • 39
    • 84881356899 scopus 로고    scopus 로고
    • Multifunctional PLGA-based nanoparticles encapsulating simultaneously hydrophilic antigen and hydrophobic immunomodulator for mucosal immunization
    • Primard C, Poecheim J, Heuking S, Sublet E, Esmaeili F, Borchard G. Multifunctional PLGA-based nanoparticles encapsulating simultaneously hydrophilic antigen and hydrophobic immunomodulator for mucosal immunization. Mol Pharm. 2013;10(8):2996-3004.
    • (2013) Mol Pharm , vol.10 , Issue.8 , pp. 2996-3004
    • Primard, C.1    Poecheim, J.2    Heuking, S.3    Sublet, E.4    Esmaeili, F.5    Borchard, G.6
  • 40
    • 84906087828 scopus 로고    scopus 로고
    • Immunoadjuvant activity of the nanoparticles' surface modified with mannan
    • Haddadi A, Hamdy S, Ghotbi Z, Samuel J, Lavasanifar A. Immunoadjuvant activity of the nanoparticles' surface modified with mannan. Nanotechnology. 2014;25(35):355101.
    • (2014) Nanotechnology , vol.25 , Issue.35 , pp. 355101
    • Haddadi, A.1    Hamdy, S.2    Ghotbi, Z.3    Samuel, J.4    Lavasanifar, A.5
  • 41
    • 0037020525 scopus 로고    scopus 로고
    • Paclitaxel-loaded PLGA nanoparticles: Preparation, physicochemical characterization and in vitro anti-tumoral activity
    • Fonseca C, Simoes S, Gaspar R. Paclitaxel-loaded PLGA nanoparticles: preparation, physicochemical characterization and in vitro anti-tumoral activity. J Control Release. 2002;83(2):273-86.
    • (2002) J Control Release , vol.83 , Issue.2 , pp. 273-286
    • Fonseca, C.1    Simoes, S.2    Gaspar, R.3
  • 42
    • 84902470064 scopus 로고    scopus 로고
    • Development and evaluation of paclitaxel loaded PLGA: Poloxamer blend nanoparticles for cancer chemotherapy
    • Gupta PN, Jain S, Nehate C, Alam N, Khare V, Dubey RD, et al. Development and evaluation of paclitaxel loaded PLGA: poloxamer blend nanoparticles for cancer chemotherapy. Int J Biol Macromol. 2014;69:393-399.
    • (2014) Int J Biol Macromol , vol.69 , pp. 393-399
    • Gupta, P.N.1    Jain, S.2    Nehate, C.3    Alam, N.4    Khare, V.5    Dubey, R.D.6
  • 43
    • 79955832587 scopus 로고    scopus 로고
    • Comparison of intracellular accumulation and cytotoxicity of free mTHPC and mTHPC-loaded PLGA nanoparticles in human colon carcinoma cells
    • Löw K, Knobloch T, Wagner S, Wiehe A, Engel A, Langer K, et al. Comparison of intracellular accumulation and cytotoxicity of free mTHPC and mTHPC-loaded PLGA nanoparticles in human colon carcinoma cells. Nanotechnology. 2011;22(24):245102.
    • (2011) Nanotechnology , vol.22 , Issue.24 , pp. 245102
    • Löw, K.1    Knobloch, T.2    Wagner, S.3    Wiehe, A.4    Engel, A.5    Langer, K.6
  • 44
    • 70350597706 scopus 로고    scopus 로고
    • Development of a PLGA nanoparticle drug delivery system containing imaging/hyperthermia and chemotherapy agents
    • 15-17 May 2009. Miami, Florida, USA: Springer
    • Manchanda R, Nagesetti A, Fernandez-Fernandez A, McGoron A. Development of a PLGA Nanoparticle Drug Delivery System Containing Imaging/Hyperthermia and Chemotherapy Agents, 25th Southern Biomedical Engineering Conference 2009, 15-17 May 2009. Miami, Florida, USA: Springer; 2009. p. 183-4.
    • (2009) 25th Southern Biomedical Engineering Conference 2009 , pp. 183-184
    • Manchanda, R.1    Nagesetti, A.2    Fernandez-Fernandez, A.3    McGoron, A.4
  • 45
    • 0031877212 scopus 로고    scopus 로고
    • In vitro and in vivo release of ciprofloxacin from PLGA 50: 50 implants
    • Ramchandani M, Robinson D. In vitro and in vivo release of ciprofloxacin from PLGA 50: 50 implants. J Control Release. 1998;54(2):167-75.
    • (1998) J Control Release , vol.54 , Issue.2 , pp. 167-175
    • Ramchandani, M.1    Robinson, D.2
  • 46
    • 80052892141 scopus 로고    scopus 로고
    • Simvastatin-loaded PLGA nanoparticles for improved oral bioavailability and sustained release: Effect of formulation variables
    • Soni A, Gadad A, Dandagi P, Mastiholimath V. Simvastatin-loaded PLGA nanoparticles for improved oral bioavailability and sustained release: effect of formulation variables. Asian J Pharm. 2011;5(2):57.
    • (2011) Asian J Pharm , vol.5 , Issue.2 , pp. 57
    • Soni, A.1    Gadad, A.2    Dandagi, P.3    Mastiholimath, V.4
  • 48
    • 84888324246 scopus 로고    scopus 로고
    • Development and characterization of surface modified PLGA nanoparticles for nasal vaccine delivery: Effect of mucoadhesive coating on antigen uptake and immune adjuvant activity
    • Pawar D, Mangal S, Goswami R, Jaganathan K. Development and characterization of surface modified PLGA nanoparticles for nasal vaccine delivery: effect of mucoadhesive coating on antigen uptake and immune adjuvant activity. Eur J Pharm Biopharm. 2013;85(3):550-9.
    • (2013) Eur J Pharm Biopharm , vol.85 , Issue.3 , pp. 550-559
    • Pawar, D.1    Mangal, S.2    Goswami, R.3    Jaganathan, K.4
  • 49
    • 84870383902 scopus 로고    scopus 로고
    • The role of surface charge in cellular uptake and cytotoxicity of medical nanoparticles
    • Fröhlich E. The role of surface charge in cellular uptake and cytotoxicity of medical nanoparticles. Int J Nanomedicine. 2012;7:5577.
    • (2012) Int J Nanomedicine , vol.7 , pp. 5577
    • Fröhlich, E.1
  • 51
    • 84894032581 scopus 로고    scopus 로고
    • Cellular uptake of nanoparticles as determined by particle properties, experimental conditions, and cell type
    • Kettler K, Veltman K, van de Meent D, van Wezel A, Hendriks AJ. Cellular uptake of nanoparticles as determined by particle properties, experimental conditions, and cell type. Environ Toxicol Chem. 2014;33(3):481-92.
    • (2014) Environ Toxicol Chem , vol.33 , Issue.3 , pp. 481-492
    • Kettler, K.1    Veltman, K.2    van de Meent, D.3    van Wezel, A.4    Hendriks, A.J.5
  • 52
    • 84893019819 scopus 로고    scopus 로고
    • Imaging macrophages with nanoparticles
    • Weissleder R, Nahrendorf M, Pittet MJ. Imaging macrophages with nanoparticles. Nat Mater. 2014;13(2):125-38.
    • (2014) Nat Mater , vol.13 , Issue.2 , pp. 125-138
    • Weissleder, R.1    Nahrendorf, M.2    Pittet, M.J.3
  • 53
    • 0033653531 scopus 로고    scopus 로고
    • Nitric oxide and virus infection
    • Akaike T, Maeda H. Nitric oxide and virus infection. Immunology. 2000;101(3):300-8.
    • (2000) Immunology , vol.101 , Issue.3 , pp. 300-308
    • Akaike, T.1    Maeda, H.2
  • 54
    • 0028853663 scopus 로고
    • Role of nitric oxide in parasitic infections
    • James SL. Role of nitric oxide in parasitic infections. Microbiol Rev. 1995;59(4):533-47.
    • (1995) Microbiol Rev , vol.59 , Issue.4 , pp. 533-547
    • James, S.L.1
  • 55
    • 0033669926 scopus 로고    scopus 로고
    • Role of IL-12 in macrophage activation during intracellular infection: IL-12 and mycobacteria synergistically release TNF-α and nitric oxide from macrophages via IFN-γ induction
    • Xing Z, Zganiacz A, Santosuosso M. Role of IL-12 in macrophage activation during intracellular infection: IL-12 and mycobacteria synergistically release TNF-α and nitric oxide from macrophages via IFN-γ induction. J Leukoc Biol. 2000;68(6):897-902.
    • (2000) J Leukoc Biol , vol.68 , Issue.6 , pp. 897-902
    • Xing, Z.1    Zganiacz, A.2    Santosuosso, M.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.